New Oxford study shows steroid inhalation (like for asthma treatment) reduces the risk to be hospitalized by about 90% if taken 3 days after #COVID19 symptom onset.
Multiple early reports of patients admitted to hospital with COVID-19 showed that patients with chronic respiratory disease were significantly under-represented in these cohorts. We hypothesised that the widespread use of inhaled glucocorticoids among these patients was responsible for this finding, and tested if inhaled glucocorticoids would be an effective treatment for early COVID-19.
Advertisements
Read the Full Study Here: Inhaled budesonide in the treatment of early COVID-19
Not A News Network 